8-K: Presto Automation Secures $1.65 Million in Convertible Note Financing and Amends Cooperation Agreement
Material Definitive Agreement
Presto Automation Inc. has secured a $1.65 million convertible note and amended its cooperation agreement with lenders to extend forbearance, while also addressing potential delisting and exploring further capital raising options.
Summary
- Presto Automation Inc. has entered into a subordinated convertible note agreement for $1.65 million with Remus Capital, an entity affiliated with a board member.
- The note accrues interest at 7.5% per annum, increasing to 12% upon default, and is convertible into 20,625,000 shares of common stock at $0.08 per share.
- The total shares issued upon conversion are capped at 20% of the company's outstanding shares at the time of conversion.
- The company also amended its cooperation agreement with Metropolitan Partners Group, extending forbearance to September 15, 2024, contingent on raising up to $7.5 million in additional capital.
- The amendment requires the company to make a $375,000 cash payment to lenders and $210,000 for reimbursement of fees and expenses by August 9, 2024.
- Failure to make these payments will increase the interest rate on the credit agreement to 18% per annum, effective as of May 16, 2024.
- The company is required to file a registration statement with the SEC within 90 days to register the resale of shares issued upon conversion of the note.
- The company held a special meeting of stockholders on July 16, 2024, where proposals for a reverse stock split and the issuance of shares exceeding 20% of outstanding stock were approved.
- The company projects that the net proceeds from the July Note, along with other cash resources and projected revenues, will sustain operations through the end of July 2024.
- The company is actively exploring alternatives to raise additional capital.
Sentiment
Score: 3
Explanation: The document indicates significant financial challenges, including potential delisting, reliance on debt financing, and the need for further capital raises. While there are some positive aspects like the secured funding and extended forbearance, the overall tone suggests a high level of risk and uncertainty.
Positives
- The $1.65 million convertible note provides immediate funding to sustain operations.
- The amended cooperation agreement extends the forbearance period, providing more time to address financial obligations.
- The potential for a reverse stock split could help the company regain compliance with Nasdaq listing requirements.
- Stockholder approval for additional share issuance provides flexibility for future capital raises.
Negatives
- The company is facing potential delisting from Nasdaq, although an appeal has been filed.
- The convertible note is subordinated to existing debt, meaning it will be paid after senior lenders.
- The company's cash resources are only projected to last through the end of July 2024, indicating a need for further funding.
- Failure to meet the August 9, 2024 payment deadline will result in a significant increase in the interest rate on the credit agreement to 18%.
Risks
- The company's ability to comply with Nasdaq Listing Rule 5635(d) regarding share issuance is uncertain.
- The company's shares are currently subject to delisting from Nasdaq.
- The company's ability to raise the required $7.5 million to extend the forbearance period is not guaranteed.
- Failure to meet financial obligations could lead to an event of default and potential loss of value for common stockholders.
- The company's reliance on additional capital raises indicates ongoing financial instability.
Future Outlook
The company is exploring alternatives to raise additional capital and projects that current resources will sustain operations through the end of July 2024. The company is also working with lenders to develop a strategic plan to address its obligations.
Industry Context
The company's financial struggles and need for additional capital are indicative of the challenges faced by many technology companies in the current economic environment. The reliance on convertible notes and the potential for a reverse stock split suggest the company is under significant financial pressure.
Comparison to Industry Standards
- The use of convertible notes for financing is common among early-stage and distressed companies, but the high interest rate of 12% upon default suggests a higher risk profile than typical.
- The potential for a reverse stock split is often a sign of a company struggling to maintain its share price and avoid delisting, which is not uncommon for companies facing financial difficulties.
- The forbearance agreement and the need to raise additional capital are similar to situations faced by other companies in the technology sector that are experiencing cash flow issues.
- The company's situation is comparable to other companies that have had to negotiate with lenders to avoid bankruptcy or liquidation.
Related Party Transactions
- The convertible note was issued to Remus Capital Series B II, L.P., an entity affiliated with Krishna Gupta, a member of the Board of Directors.
Stakeholder Impact
- Shareholders face the risk of further dilution and potential loss of value due to the issuance of new shares and the possibility of a reverse stock split.
- Employees may be concerned about the company's financial stability and potential restructuring.
- Creditors are likely monitoring the company's ability to meet its financial obligations.
- Customers and suppliers may be concerned about the company's long-term viability.
Next Steps
- The company needs to file a registration statement with the SEC within 90 days.
- The company needs to make cash payments to lenders and for reimbursement of fees and expenses by August 9, 2024.
- The company needs to raise additional capital to extend the forbearance period.
- The company needs to continue to explore alternatives to raise capital.
- The company needs to work with lenders to develop and execute a strategic plan.
Key Dates
| Date | Description |
|---|---|
| 2022-09-21 | Date of the original Credit Agreement. |
| 2023-10-10 | Date of certain Securities Purchase Agreement. |
| 2023-10-16 | Date of warrants to purchase Common Stock. |
| 2023-11-15 | Date of the Stockholders Agreement. |
| 2023-11-17 | Date of certain Common Stock Purchase Agreements. |
| 2024-01-16 | Date of the Side Letter Agreement. |
| 2024-01-29 | Date of certain Securities Purchase Agreements and warrants to purchase Common Stock. |
| 2024-01-30 | Date of convertible subordinated note issued to Remus Capital Series B II, L.P. |
| 2024-03-21 | Date of secured promissory note issued to Presto CA LLC. |
| 2024-03-30 | Date of second loan made to Presto CA LLC. |
| 2024-05-16 | Date of the original Cooperation Agreement. |
| 2024-05-22 | Date of certain Securities Purchase Agreements. |
| 2024-05-28 | Date of Common Stock Purchase Agreement with Triton Funds, LP. |
| 2024-06-20 | Date of the definitive proxy statement filed with the SEC. |
| 2024-07-08 | Date used to calculate the Outstanding Balance owed to lenders. |
| 2024-07-16 | Date of the Special Meeting of Stockholders. |
| 2024-07-19 | Date of the convertible note, Registration Rights Agreement, and amendment to the Cooperation Agreement. |
| 2024-07-22 | Initial Termination Date if no capital raise is achieved. |
| 2024-08-01 | Potential Termination Date if $1.5 million is raised by July 22, 2024. |
| 2024-08-09 | Deadline for cash payments to lenders and for reimbursement of fees and expenses. |
| 2024-08-15 | Potential Termination Date if $3.5 million is raised by August 1, 2024. |
| 2024-08-29 | Potential Termination Date if $5.5 million is raised by August 15, 2024. |
| 2024-09-15 | Potential Termination Date if $7.5 million is raised by August 29, 2024. |
Keywords
convertible note, forbearance, capital raise, reverse stock split, Nasdaq delisting, subordinated debt, registration statement, cooperation agreement, financial restructuring, share issuance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.